269409-74-7Relevant articles and documents
SAR Exploration of Tight-Binding Inhibitors of Influenza Virus PA Endonuclease
Credille, Cy V.,Morrison, Christine N.,Stokes, Ryjul W.,Dick, Benjamin L.,Feng, Yifan,Sun, Jiaxing,Chen, Yao,Cohen, Seth M.
supporting information, p. 9438 - 9449 (2019/10/28)
Significant efforts have been reported on the development of influenza antivirals including inhibitors of the RNA-dependent RNA polymerase PA N-terminal (PAN) endonuclease. Based on recently identified, highly active metal-binding pharmacophore
HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH
-
Page/Page column 145, (2008/12/05)
Provided herein are Heteroaryl Compounds having the following structure: (I) wherein R1, R2, L, X, Y, Z, Q, A and B are as defined herein, compositions comprising an effective amount of a Heteroaryl Compound and methods for treating or preventing cancer, inflammatory conditions, immunological conditions, metabolic conditions and conditions treatable or preventable by inhibition of a kinase pathway comprising administering an effective amount of a Heteroaryl Compound to a patient in need thereof.
NOVEL COMPOUNDS
-
Page/Page column 180-181, (2010/11/29)
Novel substituted 1,5,7-trisubstituted-3,4-dihydro-pyrimido[4,5-d]pyrimidin-2-(1H)-one compounds and compositions, and their use in therapy as CSBP/RK/p38 kinase inhibitors.